Evidence map›Paper›PMID 31718580›Full record

ArticleBMC infectious diseases2019

Genomic epidemiology supports multiple introductions and cryptic transmission of Zika virus in Colombia.

Allison Black, Louise H Moncla, Katherine Laiton-Donato, Barney Potter, Lissethe Pardo, Angelica Rico, Catalina Tovar, Diana P Rojas, Ira M Longini, M Elizabeth Halloran and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Allison BlackDepartment of Epidemiology, University of Washington, Seattle, Washington, United States.
Louise H MonclaVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States.
Katherine Laiton-DonatoLaboratorio de Virología, Subdirección de Laboratorio Nacional de Referencia, Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
Barney PotterVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States.
Lissethe PardoLaboratorio de Virología, Subdirección de Laboratorio Nacional de Referencia, Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
Angelica RicoLaboratorio de Virología, Subdirección de Laboratorio Nacional de Referencia, Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
Catalina TovarGrupo de Enfermedades Tropicales y Resistencia Bacteriana, Facultad de Ciencias de la Salud, Universidad del Sinú, Montería, Córdoba, Colombia.
Diana P RojasDepartment of Biostatistics, University of Florida, Gainesville, Florida, United States.
Ira M LonginiDepartment of Biostatistics, University of Florida, Gainesville, Florida, United States.
M Elizabeth HalloranDepartment of Epidemiology, University of Washington, Seattle, Washington, United States.
Dioselina Peláez-CarvajalLaboratorio de Virología, Subdirección de Laboratorio Nacional de Referencia, Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
Juan D RamírezGrupo de Investigaciones Microbiológicas-UR (GIMUR), Departamento de Biología,Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Bogotá, Colombia.
Marcela Mercado-ReyesLaboratorio de Virología, Subdirección de Laboratorio Nacional de Referencia, Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
Trevor BedfordDepartment of Epidemiology, University of Washington, Seattle, Washington, United States. trevor@bedford.io.
Instituto Nacional de Salud · COFred Hutch Cancer Center · USUniversity of Florida · USUniversidad del Rosario · COUniversidad del Sinú · COUniversity of Washington · US

Funding

Understanding Transmission with Integrated Genetic and Epidemiologic InferenceU54GM111274 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BEDFORD, TREVOR BC · 2014 to 2018
$12.5M
Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigationR35GM119774 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BEDFORD, TREVOR BC · 2016 to 2025
$4.1M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
Gobernacion de Cordoba 754/2013National Science Foundation DGE-1256082NIGMS NIH HHS R35 GM119774NIGMS NIH HHS U54 GM111274NIH HHS R35 GM119774-01NIH HHS S10 OD020069NIH HHS U54 GM111274
6 · The paper itself

Abstract

backgroundColombia was the second most affected country during the American Zika virus (ZIKV) epidemic, with over 109,000 reported cases. Despite the scale of the outbreak, limited genomic sequence data were available from Colombia. We sought to sequence additional samples and use genomic epidemiology to describe ZIKV dynamics in Colombia.

methodsWe sequenced ZIKV genomes directly from clinical diagnostic specimens and infected Aedes aegypti samples selected to cover the temporal and geographic breadth of the Colombian outbreak. We performed phylogeographic analysis of these genomes, along with other publicly-available ZIKV genomes from the Americas, to estimate the frequency and timing of ZIKV introductions to Colombia.

resultsWe attempted PCR amplification on 184 samples; 19 samples amplified sufficiently to perform sequencing. Of these, 8 samples yielded sequences with at least 50% coverage. Our phylogeographic reconstruction indicates two separate introductions of ZIKV to Colombia, one of which was previously unrecognized. We find that ZIKV was first introduced to Colombia in February 2015 (95%CI: Jan 2015 - Apr 2015), corresponding to 5 to 8 months of cryptic ZIKV transmission prior to confirmation in September 2015. Despite the presence of multiple introductions, we find that the majority of Colombian ZIKV diversity descends from a single introduction. We find evidence for movement of ZIKV from Colombia into bordering countries, including Peru, Ecuador, Panama, and Venezuela.

conclusionsSimilarly to genomic epidemiological studies of ZIKV dynamics in other countries, we find that ZIKV circulated cryptically in Colombia. More accurately dating when ZIKV was circulating refines our definition of the population at risk. Additionally, our finding that the majority of ZIKV transmission within Colombia was attributable to transmission between individuals, rather than repeated travel-related importations, indicates that improved detection and control might have succeeded in limiting the scale of the outbreak within Colombia.

Indexed as

Genome, ViralAedesAnimalsColombiaDisease OutbreaksEvolution, MolecularGenetic VariationHumansPhylogenyPhylogeographyZika VirusZika Virus InfectionColombiaGenomic epidemiologyPhylogeographyVirus evolutionZika virus

Identifiers

PMID31718580
PMCPMC6852897
OpenAlexW2988541819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.